427 Development of iPSC-derived cytotoxic CD8+ T-cells as the basis for innovative off-the-shelf cancer immunotherapies - Daniel Sommermeyer; Chloé Beuraud; Monika Braun; Michael Epstein; Philip Hublitz; Michael Esquerré; Audrey Holtzinger; Nadja Wagner; Riga Tawo; Florie Bertrand; Olivia Cypris; Pauline Barron; et al. (Journal for ImmunoTherapy of Cancer, 2023)